Platinum Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.55M Hold
30,102
1.65% 14
2025
Q4
$6.88M Sell
30,102
-340,057
-92% -$77.5M 1.59% 12
2025
Q3
$85.7M Buy
370,159
+4,719
+1% +$961K 5.54% 3
2025
Q2
$67.8M Sell
365,440
-52,927
-13% -$9.84M 4.51% 10
2025
Q1
$87.7M Buy
+418,367
New +$81.3M 5.08% 9

Other funds holding ABBV

Platinum Investment Management's ABBV Position: Q1 2026 in Review

Platinum Investment Management held its AbbVie (ABBV) position steady in Q1 2026 at 30,102 shares worth $6.55M. The position accounts for 1.65% of the portfolio, ranked #14.

Platinum Investment Management first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. The position peaked at $87.7M in Q1 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Platinum Investment Management held 30,102 shares of AbbVie worth $6.55M as of Q1 2026.
  • Platinum Investment Management left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 1.65% of Platinum Investment Management's portfolio in Q1 2026, its #14 holding.
  • Platinum Investment Management first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • Platinum Investment Management's AbbVie position peaked at $87.7M in Q1 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Platinum Investment Management's 13F filing for Q1 2026, filed 14 May 2026.